<DOC>
	<DOC>NCT01092299</DOC>
	<brief_summary>Part 1: The purpose of this study is to determine the pharmacokinetic profile of 4 different Extended/modified-release formulations and one immediate release formulation of AZD1446. In addition the food effect on AZD1446 pharmacokinetics will be investigated. Part 2: To asses the safety and tolerability of the selected formulation(s) from part 1 in elderly healthy volunteers.</brief_summary>
	<brief_title>A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions</brief_title>
	<detailed_description />
	<criteria>Body mass index (BMI) between 19 and 30 kg/m2 Clinically normal findings on physical examination History of any clinically significant disease or disorder History or presence of gastrointestinal, hepatic or renal disease or any other condition known to interfere with absorption, distribution, metabolism or excretion of drugs History or present symptoms or signs of severe allergy/hypersensitivity reactions including severe food allergy, as judged by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Relative bioavailability</keyword>
	<keyword>Pharmacokinetic study</keyword>
	<keyword>AZD1446</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>